Smith Stan has exercised stock options for 38,871 shares in MAIA Biotechnology, Inc. This transaction, reported in a recent SEC filing, is significant as it reflects Stan's confidence in the company's prospects and aligns executive compensation with company performance.

Background

MAIA Biotechnology, Inc. operates in the pharmaceutical preparations sector, focusing on developing innovative therapies. The company is based in Chicago, Illinois, and is publicly traded under the ticker symbol MAIA. Smith Stan, the reporting owner, is associated with MAIA through his role as a director.

What the Filing Says

The SEC filing indicates that the stock options were granted on September 30, 2026, as part of MAIA's 2021 Equity Incentive Plan. The options have an exercise price of $1.18 per share and vest 100% on the grant date. Following this transaction, Stan owns 38,871 shares of common stock in MAIA.

Impact

This exercise may influence MAIA's stock performance and investor sentiment, particularly as the pharmaceutical industry continues to evolve. Stakeholders, including investors and analysts, will likely monitor how this aligns with MAIA's strategic goals and market performance.

What's Next

The filing does not say what happens next.

Details of the Stock Options

The stock options exercised by Smith Stan were granted as part of MAIA's 2021 Equity Incentive Plan, which aims to attract and retain talented individuals by providing them with equity-based compensation. The options have an expiration date of September 30, 2036, allowing Stan a ten-year window to exercise these options.

Ownership Structure

According to the filing, the securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993, indicating a structured approach to his investment in MAIA. This trust structure may provide certain tax advantages and estate planning benefits.

Company Information

MAIA Biotechnology, Inc. is incorporated in Delaware and operates in the pharmaceutical preparations sector, classified under the Standard Industrial Classification code 2834. The company is headquartered at the same address as Smith Stan, which may facilitate close collaboration between the director and the company.

Filing Specifics

The SEC filing was submitted on October 2, 2026, with a report period ending September 30, 2026. The form type is categorized as a Form 4, which is used to report changes in ownership of securities by insiders.